Other
Settlement expense
Biogen Settlement expense increased by 56.7% to $4.7M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 56.7%, from $3M to $4.7M.
Analysis
StatementIncome Statement
SectionOther
First reportedQ1 2014
Last reportedQ1 2026Apr 29, 2026
Metric ID:
other_litigation_settlement_expenseHistorical Data
8 periods
| Q2 '21 | Q3 '21 | Q2 '22 | Q3 '22 | Q2 '23 | Q3 '23 | Q1 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|
| Value | $0 | $0 | $900M | $0 | $0 | $0 | $3M | $4.7M |
| QoQ Change | — | — | — | -100.0% | — | — | — | +56.7% |
| YoY Change | — | — | — | — | -100.0% | — | — | +56.7% |
Range$0 – $900M
Avg YoY Growth-21.7%
Median YoY Growth-21.7%
Frequently Asked Questions
- What is Biogen's settlement expense?
- Biogen (BIIB) reported settlement expense of $4.7M in Q1 2026.
- How has Biogen's settlement expense changed year-over-year?
- Biogen's settlement expense increased by 56.7% year-over-year, from $3M to $4.7M.